Sean Grant - 13 Jul 2021 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Chief Financial Officer
Signature
Sean Grant, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
VERA
Transactions as of
13 Jul 2021
Net transactions value
$0
Form type
4
Filing time
15 Jul 2021, 16:22:37 UTC
Previous filing
15 Jul 2021
Next filing
18 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Option (right to buy) Award $0 +180,000 $0.000000 180,000 13 Jul 2021 Class A Common Stock 180,000 $14.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the shares subject to the option vest on July 12, 2022, and 1/48 of the shares vest monthly thereafter.